Report cover image

Sera Prognostics Inc (SERA) - Product Pipeline Analysis, 2025 Update

Publisher GlobalData
Published Feb 16, 2026
Length 32 Pages
SKU # GBDT20881385

Description

Summary

Sera Prognostics Inc (Sera Prognostics) is a biotechnology firm, that specializes in providing diagnostic tests for predicting the risk of pregnancy complications such as premature birth and preeclampsia. It offers PreTRM, a proteomic predictor of premature birth risk for clinicians, mothers and doctors to deliver personalized care plans and treatments for improving the newborn and maternal health. Its offerings are used by payers, employers, healthcare providers, moms. It also offers services such as women health diagnostics. Sera Prognostics is headquartered in Salt Lake, Utah, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Sera Prognostics Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company

Table of Contents

32 Pages
Sera Prognostics Inc Company Overview
Sera Prognostics Inc Company Snapshot
Sera Prognostics Inc Pipeline Products and Ongoing Clinical Trials Overview
Sera Prognostics Inc – Pipeline Analysis Overview
Sera Prognostics Inc - Key Facts
Sera Prognostics Inc - Major Products and Services
Sera Prognostics Inc Pipeline Products by Development Stage
Sera Prognostics Inc Pipeline Products Overview
Biomarker Test - Fetal Growth Restriction
Biomarker Test - Fetal Growth Restriction Product Overview
Biomarker Test - Gestational Diabetes Mellitus
Biomarker Test - Gestational Diabetes Mellitus Product Overview
Biomarker Test - Molecular Time-to-Birth
Biomarker Test - Molecular Time-to-Birth Product Overview
Biomarker Test - Postpartum Depression
Biomarker Test - Postpartum Depression Product Overview
Biomarker Test - Stillbirth
Biomarker Test - Stillbirth Product Overview
Diagnostic Test - Preeclampsia
Diagnostic Test - Preeclampsia Product Overview
Predictive Analytics Test
Predictive Analytics Test Product Overview
Pregnancy Risk Prediction Panel
Pregnancy Risk Prediction Panel Product Overview
Sera Prognostics Inc - Key Competitors
Sera Prognostics Inc - Key Employees
Sera Prognostics Inc - Locations And Subsidiaries
Head Office
Recent Developments
Sera Prognostics Inc, Recent Developments
Jan 07, 2026: Hera Women's Health Highlights Sera Prognostics PRIME Trial Results Led by Brian K. Iriye, MD Showing Biomarker-Guided Care Improves Newborn Outcomes and Reduces NICU Use
Jan 07, 2026: Landmark Study Finds PreTRM Blood Test Reduces Earliest Preterm Births and Newborn Complications
Nov 24, 2025: Sera Announces Publication Acceptance for PRIME Study
Oct 31, 2025: Sera Prognostics Announces Conference Call and Webcast of Third Quarter Fiscal Year 2025 Financial Results on November 13, 2025
Jul 29, 2025: Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2025 Financial Results on August 6, 2025
Mar 19, 2025: Sera Prognostics Adds Jeff Elliott to Board
Dec 04, 2024: Sera Prognostics to Present PRIME Study Results at 2025 SMFM Pregnancy Meeting
Jul 25, 2024: Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2024 Financial Results on August 7, 2024
Jul 09, 2024: Sera Prognostics PreTRM Test Prevention Strategy Demonstrates 18% Reduction in Severe Neonatal Morbidity and Mortality in Newly Published AVERT Trial
Oct 25, 2023: Sera Prognostics Announces Conference Call and Webcast of Third Quarter Fiscal Year 2023 Financial Results on November 8, 2023
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Sera Prognostics Inc Pipeline Products and Ongoing Clinical Trials Overview
Sera Prognostics Inc Pipeline Products by Equipment Type
Sera Prognostics Inc Pipeline Products by Indication
Sera Prognostics Inc, Key Facts
Sera Prognostics Inc, Major Products and Services
Sera Prognostics Inc Number of Pipeline Products by Development Stage
Sera Prognostics Inc Pipeline Products Summary by Development Stage
Biomarker Test - Fetal Growth Restriction - Product Status
Biomarker Test - Fetal Growth Restriction - Product Description
Biomarker Test - Gestational Diabetes Mellitus - Product Status
Biomarker Test - Gestational Diabetes Mellitus - Product Description
Biomarker Test - Molecular Time-to-Birth - Product Status
Biomarker Test - Molecular Time-to-Birth - Product Description
Biomarker Test - Postpartum Depression - Product Status
Biomarker Test - Postpartum Depression - Product Description
Biomarker Test - Stillbirth - Product Status
Biomarker Test - Stillbirth - Product Description
Diagnostic Test - Preeclampsia - Product Status
Diagnostic Test - Preeclampsia - Product Description
Predictive Analytics Test - Product Status
Predictive Analytics Test - Product Description
Pregnancy Risk Prediction Panel - Product Status
Pregnancy Risk Prediction Panel - Product Description
Sera Prognostics Inc, Key Employees
Glossary
List of Figures
Sera Prognostics Inc Pipeline Products by Equipment Type
Sera Prognostics Inc Pipeline Products by Development Stage

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us